ArticleCardiovascular diabetology2023

Comparative cardiovascular outcomes in type 2 diabetes patients taking dapagliflozin versus empagliflozin: a nationwide population-based cohort study.

Jaehyun Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.